Concepedia

Masoud Khorsand

MK

Statistics

Publications

7

Citations

304

H-Index

7

Active since

1996

Affiliations

University of Wisconsin–Madison(Current)

University of Wisconsin Carbone Cancer Center

Masoud Khorsand is an author at University of Wisconsin–Madison specializing in oncology, cancer immunotherapy, and cytokine therapy.

Publications per year

1996–2001

7

Publications

7

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

Mark R. Albertini, Jacquelyn A. Hank, Joan H. Schiller et al. · PubMed · 1997 · 71 citations

, , +17

Multiple cerebral lesions complicating therapy with interleukin-2

Barbara Karp, Jin Yang, Masoud Khorsand et al. · Neurology · 1996 · 52 citations

, , +15

Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder

Masoud Khorsand, J Lange, Lynn G. Feun et al. · Investigational New Drugs · 1997 · 47 citations

, , +11

Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2

Michael E. Eastman, Masoud Khorsand, Dennis G. Maki et al. · Cancer · 2001 · 43 citations

, , +17

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.

Joan H. Schiller, Jacquelyn A. Hank, Masoud Khorsand et al. · PubMed · 1996 · 37 citations

, , +15

1–5 of 7